Literature DB >> 10387141

Generic antiarrhythmic drugs: what constitutes equivalency.

D G Benditt1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10387141     DOI： 10.1023/a:1009817413845

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  6 in total

Review 1.  Bioequivalence assessment of generic drugs: an American point of view.

Authors:  R Patnaik; L J Lesko; K Chan; R L Williams
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 2.  Generics: what's in a name?

Authors:  L G Keith; J J Oleszczuk; C S Stika; S Stine
Journal:  Int J Fertil Womens Med       Date:  1998 May-Jun

Review 3.  Therapeutic inequivalence.

Authors:  P H Rheinstein
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

Review 4.  Bioequivalence and generic prescribing: an industrial view.

Authors:  A Pidgen
Journal:  J Pharm Pharmacol       Date:  1996-01       Impact factor: 3.765

5.  Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine.

Authors:  A Johnston; P A Keown; D W Holt
Journal:  Ther Drug Monit       Date:  1997-08       Impact factor: 3.681

6.  Clinical relevance of the bioavailability/bioequivalence controversy.

Authors:  L A Gottschalk
Journal:  J Clin Psychiatry       Date:  1986-09       Impact factor: 4.384
  6 in total
  2 in total

1.  Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.

Authors:  Meytal A Tsadok; Cynthia A Jackevicius; Elham Rahme; Vidal Essebag; Mark J Eisenberg; Karin H Humphries; Jack V Tu; Hassan Behlouli; Jennifer Joo; Louise Pilote
Journal:  CMAJ       Date:  2011-07-11       Impact factor: 8.262

Review 2.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.